Synlait Unveils $80m Loss and Bold Recovery Plan with Asset Sale
Synlait Milk Limited has reported a significant half-year loss driven by manufacturing setbacks and market pressures, alongside a strategic recovery roadmap focused on asset sales and operational overhaul.
- Reported EBITDA loss of $34.7 million and net loss after tax of $80.6 million
- Revenue increased slightly to $949 million despite profit decline
- Manufacturing disruptions and lower ingredient returns created a 'perfect storm'
- Announced sale of North Island assets as part of recovery strategy
- Recovery roadmap titled 'Stabilise, Simplify and Scale' aims to rebuild financial resilience
A Challenging Half-Year for Synlait
Synlait Milk Limited has disclosed a disappointing financial performance for the six months ending 31 January 2026, reporting a reported EBITDA loss of $34.7 million and a net loss after tax of $80.6 million. Despite a modest revenue increase to $949 million, the company’s profitability took a significant hit, reflecting a confluence of operational and market challenges.
CEO Richard Wyeth candidly described the results as “frustratingly disappointing,” attributing the losses to a lack of strategic options rather than a lack of effort. The company faced a series of headwinds, including manufacturing disruptions at its Dunsandel facility, which forced a revision of production plans and led to surplus milk that could not be sold as intended.
The Perfect Storm: Manufacturing and Market Pressures
The manufacturing issues compelled Synlait to pause catch-up production, limiting output to whole milk powder due to dryer configurations. This coincided with a sharp decline in whole milk powder prices late in 2025, severely impacting the company’s ingredients business unit and compounding financial losses. Additionally, Synlait adopted a conservative stance on recognising deferred tax assets, further weighing on reported results.
Board Chair George Adams acknowledged the gravity of the situation, emphasising that while the current financials are disappointing, they do not define Synlait’s future. The company is moving swiftly to implement a recovery roadmap designed to restore stability and position Synlait for growth.
Roadmap to Recovery: Stabilise, Simplify and Scale
Synlait’s recovery strategy, aptly named 'Stabilise, Simplify and Scale,' outlines a three-phase approach. The first phase focuses on operational stability and financial resilience, including the imminent sale of the company’s North Island assets, expected to simplify operations and strengthen the balance sheet.
The second phase aims to sharpen organisational priorities and capabilities, concentrating on high-margin products to improve profitability. The final phase targets accelerated growth through market expansion and enhanced customer relationships, leveraging Synlait’s South Island assets.
Both Wyeth and Adams expressed a strong commitment to delivering tangible improvements over the next 12 to 24 months, with a clear message that the company intends to under-promise and over-deliver as it navigates this turnaround.
Looking Ahead
While the North Island asset sale is a pivotal step, the broader recovery depends on effective execution of the roadmap and market conditions stabilising. Investors will be watching closely to see if Synlait can translate this strategic reset into sustainable profitability and renewed growth.
Bottom Line?
Synlait’s next moves will test whether its bold recovery plan can turn losses into lasting gains.
Questions in the middle?
- How will the North Island asset sale impact Synlait’s financial health and operational focus?
- Can Synlait’s ingredients business rebound amid volatile whole milk powder prices?
- What milestones will signal genuine progress in the 'Stabilise, Simplify and Scale' roadmap?
